In the same way, the data of immunohistochemical analyses have indicated that HIF-2α was co-expressed with CD133 stem cell-like marker in GBM tissue specimens, and associated with a poor survival of glioma patients [127]. This evidence concerns the gene PROM1 and glioblastoma.